| Business Summary | | Dr.
Reddy's
Laboratories
Limited
is
a
fully
integrated
pharmaceutical
organization.
The
Company
has
expertise
in
the
development
and
manufacture
of
organic
intermediates,
bulk
actives
and
finished
dosage
forms.
The
finished
dosage
business
derives
its
strength
from
its
integrated
research
and
development
facility
with
scale-up
facilities
for
commercialization.
The
generic
finished
dosages
business
became
commercially
operational
in
1997.
The
Custom
Chemical
Services
business
unit
caters
to
the
process
research,
chemical
development,
chemical
synthesis
and
contract
manufacturing
needs
of
pharmaceutical
companies
that
wish
to
outsource
their
requirements.
The
Biotechnology
division
covers
areas
of
therapeutics,
vaccines
and
diagnostics.
Dr.
Reddy's
Laboratories
markets
a
portfolio
of
over
50
products
including
ELISA
kits
covering
hormones,
infectious
diseases
and
cancer
markets,
enzymatic
and
chemical
kits
and
pregnancy
detection
kits. | More
from
Market Guide: Expanded
Business Description |
| Financial Summary | | Dr.
Reddys'
Laboratories
Limited
is
a
pharmaceutical
company
that
develops,
manufactures
and
markets
a
wide
range
of
pharmaceutical
products
in
India
and
abroad.
For
the
six
months
ended
9/30/00,
revenues
increased
39%
to
RS3.72
billion.
Net
income
decreased
13%
to
RS225.9
million.
Revenues
reflect
the
acquisition
of
Remedies,
and
increased
sales
of
existing
brands.
Earnings
were
offset
by
increased
amortization
expenses. | More
from
Market Guide: Significant
Developments |
| Officers | | K. Anji
Reddy,
Chmn. G.V. Prasad,
Vice-Chmn./CEO Satish
Reddy
Kallam,
COO V.S. Vasudevan,
CFO. | More
from
Market Guide on Officers & Directors: Expanded
List, Bios,
Compensation,
Options
|
|